Clinical studyHigh density lipoprotein as a protective factor against coronary heart disease: The Framingham study
References (37)
- et al.
Serum lipids, hypertension and coronary artery disease
Am J Med
(1961) - et al.
Ischemic heart disease in relation to fasting values of plasma triglycerides and cholesterol
Lancet
(1972) - et al.
Quantitative and qualitative serum lipoprotein analysis. 2. Studies in male survivors of myocardial infarction
Atherosclerosis
(1975) - Goldbourt Uri, Medalie JH: Cholesterol in alpha lipoprotein and clinical myocardial infarction. Submitted for...
- et al.
Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men
N Engl J Med
(1976) - et al.
Longevity syndromes
Circulation
(1975) - et al.
A study of serum lipoproteins in normal and atherosclerotic patients by paper electropharetic techniques
J Clin Invest
(1956) - et al.
Plasma-high-density-lipoprotein concentration and development of ischemic heart disease
Lancet
(1975) Lipid metabolism in cultured cells. 4. Serum alpha-globulin and cellular cholesterol exchange
Exp Cell Res
(1965)- et al.
Cholesterol excretion by tissue culture cells. Effect of serum lipids
Biochim Biophys Acta
(1969)
HDL dependent elimination of cholesterol from human arterial tissue
Familial lipoprotein deficiency (Tangier disease)
Effects of high density lipoprotein (HDL) on low density lipoprotein (LDL) metabolism by pig smooth muscle cells (SMC)
Circulation
(1975)
Ischemic heart disease, atherosclerosis and longevity
Circulation
(1966)
Serum cholesterol lipoproteins, and risk of coronary heart diseases. The Framingham Study
Ann Intern Med
(1971)
Introduction and general background in the Framingham Study. The Framingham Study
(1968)
Some characteristics related to the incidence of cardiovascular disease and death. Framingham Study: 18-year follow-up
Fat transport and lipoproteins—an integrated approach to mechanisms and disorders
N Engl J Med
(1967)
et al.Fat transport and lipoproteins—an integrated approach to mechanisms and disorders
N Engl J Med
(1967)
et al.Fat transport and lipoproteins—an integrated approach to mechanisms and disorders
N Engl J Med
(1967)
et al.Fat transport and lipoproteins—an integrated approach to mechanisms and disorders
N Engl J Med
(1967)
et al.Fat transport and lipoproteins—an integrated approach to mechanisms and disorders
N Engl J Med
(1967)
Cited by (4237)
Overexpression of CuZn superoxide dismutase improves high-density lipoprotein function in swine
2024, Prostaglandins and Other Lipid MediatorsNonlinear relationship between high-density lipoprotein cholesterol and cardiovascular disease: an observational and Mendelian randomization analysis
2024, Metabolism: Clinical and ExperimentalCardiovascular risk: From overweight to Framingham
2024, Archives des Maladies du Coeur et des Vaisseaux - PratiqueUpdate of HDL in atherosclerotic cardiovascular disease
2023, Clinica e Investigacion en ArteriosclerosisDevelopment and validation of a purification system for functional full-length human SR-B1 and CD36
2023, Journal of Biological Chemistry
- 1
From the Framingham Heart Disease Epidemiology Study, National Heart, Lung and Blood Institute, Bethesda, Maryland.
Copyright © 1977 Published by Excerpta Medica Inc.